Cite
HARVARD Citation
Quigley, E. et al. (2023). Editorial: bacterial gut symbionts as live biotherapeutic agents in IBS—a rosy future despite potential long‐term safety concerns. Authorsʼ reply. Alimentary pharmacology & therapeutics. 57 (3), pp. 347-348. [Online].